PubMed=11751535; DOI=10.1093/clinchem/48.1.25
Nathalie Zammatteo, Laurence Lockman, Francis Brasseur, Etienne De Plaen, Christophe Lurquin, Pierre-Emmanuel Lobert, Sandrine Hamels, Thierry Boon, Jose Remacle;
DNA microarray to monitor the expression of MAGE-A genes.
Clin. Chem. 48:25-34(2002)

PubMed=15585611; DOI=10.1158/1078-0432.CCR-04-0072
Scott Simon Tykodi, Edus Houston Warren, John A. Thompson, Stanley R. Riddell, Richard W. Childs, Brith E. Otterud, Mark F. Leppert, Rainer Storb, Brenda M. Sandmaier;
Allogeneic hematopoietic cell transplantation for metastatic renal cell carcinoma after nonmyeloablative conditioning: toxicity, clinical response, and immunological response to minor histocompatibility antigens.
Clin. Cancer Res. 10:7799-7811(2004)

PubMed=18698046; DOI=10.1158/1078-0432.CCR-08-0028; PMCID=PMC2693478
Scott Simon Tykodi, Nobuharu Fujii, Nathalie Vigneron, Sharon M. Lu, Jeffrey K. Mito, Maureen X. Miranda, Jeffrey Chou, Lilien N. Voong, John A. Thompson, Brenda M. Sandmaier, Peter Cresswell ...Show all 14 authors... , Benoit J. van den Eynde, Stanley R. Riddell, Edus Houston Warren; Show fewer authors
C19orf48 encodes a minor histocompatibility antigen recognized by CD8+ cytotoxic T cells from renal cell carcinoma patients.
Clin. Cancer Res. 14:5260-5269(2008)

PubMed=22892449; DOI=10.1097/CJI.0b013e318261d630; PMCID=PMC3423552
Scott Simon Tykodi, Shoko Satoh, Janise D. Deming, Jeffrey Chou, Richard Harrop, Edus Houston Warren;
CD8+ T-cell clones specific for the 5T4 antigen target renal cell carcinoma tumor-initiating cells in a murine xenograft model.
J. Immunother. 35:523-533(2012)